InflaRx (IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...

According to Dr. Dawn Nolt, a pediatric infectious disease physician at Oregon Health and Science University, many of the ...

The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...

This easy-to-use rapid test can give you peace of mind The new year has just begun, but flu season is in full swing, with the ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...

San Francisco's Public Health Director Dr. Grant Colfax is stepping down after spending nearly six years as the city's ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

FOX 13's Lloyd Sowers reports on the FDA approving OneBlood's High Titer COVID-19 convalescent plasma treatment for immunocompromised patients.

The latest round of the COVID inquiry focuses on vaccines and anti-viral treatment across the UK. Today we hear from several ...

No scientific studies have established a causal relationship between the Pfizer vaccine and conditions that cause the excessive growth of breasts.